“…Although traditionally G protein-coupled receptors (GPCRs), such as the dopamine receptors, have been depicted as monomeric entities, it is now widely accepted that GPCRs exist as oligomeric complexes (George et al, 2002;Milligan, 2004;Terrillon and Bouvier, 2004), and homomerization has been repeatedly shown to have a critical involvement in important cellular processes, such as receptor translocation to the plasma membrane (Hague et al, 2004;Karpa et al, 2000;Kong et al, 2006;López-Giménez et al, 2007;Salahpour et al, 2004;White et al, 1998). In addition, the discovery that dopamine receptors could form heteromeric complexes (Baragli et al, 2007;Ferrada et al, 2008Ferrada et al, , 2009Ginés et al, 2000;Hillion et al, 2002;Lee et al, 2004;Marcellino et al, 2008a;Marcellino et al, 2008b;Scarselli et al, 2001;Torvinen et al, 2005) has opened up novel avenues of research for drug discovery, as many of these receptor heteromers may exhibit discrete distributions in brain with pharmacological and functional properties distinct from their constituent receptors. For example, the dopamine D1-D2 receptor heteromer was first identified in rat striatum and shown to couple to the Gq/11 protein, a finding that effectively linked dopamine directly to calcium signaling in brain (Rashid et al, 2007a).…”